Error loading player: No playable sources found
Design Considerations for ATMP Manufacturing Facilities
Date
June 27, 2023
Explore related products in the following collection:
Considerations in the design of ATMP Manufacturing Facilities will be outlined and discussed. Design challenges for both Allogenic and Autologous Cell Therapy and Gene Therapy manufacturing will be reviewed. Unique aspects of manufacturing supports such as material controls and sampling requirements will also be outlined including some case studies.
Speaker
Project Manager Consultant, Fastnet Consulting Group
Related Products
Cell and Gene Therapy Critical Starting Material – Establishing Release Specifications for Plasmids
Effective control of plasmid DNA is paramount since plasmids are critical starting materials for the generation of viral vectors and mRNA used in many cell and gene therapies…
Downstream Process Development for High Productivity Purification of Plasmid DNA
Key challenges in pDNA manufacturing exist around purification unit operations due to its large size, high viscosity, shear sensitivity, and similarities between pDNA and impurities…
Panel Discussion with Speakers from Track 6: Part 1
Following the three presentations by Alfred Penfold, Tom Bannon, Richard Shah, Scott Brady, Aine Brennan and Thomas Page, you'll have the chance you ask your questions…
